Share this article on:

A Randomized, Double-Blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Single-Tablet Regimen Efavirenz/Emtricitabine/Tenofovir DF for Initial Treatment of HIV-1 Infection: Analysis of Week 144 Results

Wohl, David A. MD*; Cohen, Calvin MD, MSc; Gallant, Joel E. MD, MPH; Mills, Anthony MD§; Sax, Paul E. MD; DeJesus, Edwin MD; Zolopa, Andrew MD#; Liu, Hui C. MD, PhD**; Plummer, Andrew BS**; White, Kirsten L. PhD**; Cheng, Andrew K. MD, PhD**; Rhee, Martin S. MD**; Szwarcberg, Javier MD, MPH**

JAIDS Journal of Acquired Immune Deficiency Syndromes: March 1st, 2014 - Volume 65 - Issue 3 - p e118–e120
doi: 10.1097/QAI.0000000000000057
Letters to the Editor